Novo Nordisk A/S Sponsored ADR - NVO

Novo Nordisk A/S Sponsored ADR is a global healthcare company focused on discovering, developing, manufacturing, and marketing pharmaceutical products. Novo Nordisk A/S Sponsored ADR serves patients and healthcare providers through two main business segments: Diabetes and Obesity Care, which includes therapies for diabetes, obesity, cardiovascular, and related emerging treatment areas, and Rare Disease, which addresses specialized conditions such as rare blood disorders and endocrine disorders. The company offers a broad portfolio of prescription medicines and treatment solutions used in chronic disease management across major international markets. Novo Nordisk A/S Sponsored ADR plays a significant role in the pharmaceutical industry by providing products that support long-term treatment needs in both primary care and specialty care settings.